Apimeds Pharmaceuticals US Inc Statistics Share Statistics Apimeds Pharmaceuticals US Inc has 11.58M
shares outstanding. The number of shares has increased by null%
in one year.
Shares Outstanding 11.58M Shares Change (YoY) n/a Shares Change (QoQ) n/a Owned by Institutions (%) n/a Shares Floating n/a Failed to Deliver (FTD) Shares 170 FTD / Avg. Volume 0.2%
Short Selling Information The latest short interest is 26.83K, so 0.23% of the outstanding
shares have been sold short.
Short Interest 26.83K Short % of Shares Out 0.23% Short % of Float 0.44% Short Ratio (days to cover) 1
Valuation Ratios The PE ratio is -18.24 and the forward
PE ratio is null.
Apimeds Pharmaceuticals US Inc's PEG ratio is
-0.23.
PE Ratio -18.24 Forward PE n/a PS Ratio 0 Forward PS n/a PB Ratio -18.67 P/FCF Ratio -34.57 PEG Ratio -0.23
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Apimeds Pharmaceuticals US Inc.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 0.01,
with a Debt / Equity ratio of -0.44.
Current Ratio 0.01 Quick Ratio 0.01 Debt / Equity -0.44 Debt / EBITDA -0.47 Debt / FCF -0.81 Interest Coverage -10.83
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-695K Employee Count 2 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by null% in the
last 52 weeks. The beta is 0, so Apimeds Pharmaceuticals US Inc's
price volatility has been lower than the market average.
Beta 0 52-Week Price Change n/a 50-Day Moving Average 1.81 200-Day Moving Average n/a Relative Strength Index (RSI) 40.29 Average Volume (20 Days) 83,803
Income Statement
Revenue n/a Gross Profit n/a Operating Income -1.28M Net Income -1.39M EBITDA -1.27M EBIT -1.27M Earnings Per Share (EPS) -0.12
Full Income Statement Balance Sheet The company has 3.46K in cash and 596.84K in
debt, giving a net cash position of -593.39K.
Cash & Cash Equivalents 3.46K Total Debt 596.84K Net Cash -593.39K Retained Earnings -4.39M Total Assets 259.9K Working Capital -1.51M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -733.53K
and capital expenditures 0, giving a free cash flow of -733.53K.
Operating Cash Flow -733.53K Capital Expenditures n/a Free Cash Flow -733.53K FCF Per Share -0.06
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
